Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Retrovirus Life Cycles

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...

Sexually Transmitted Infections

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...

Immunodeficiency Diseases

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Single-cell analysis of HIV expression and integration sites reveals robust viral expression across diverse chromatin environments.

Microbiology spectrum·2026

Same author

A screen of chromatin-targeting compounds identifies TAF1 as a novel regulator of HIV latency.

mBio·2026

Same author

MVA.HIVconsvX vaccination-evoked T cell expansion inversely associates with age in people with HIV-1 on antiretroviral therapy.

The Journal of clinical investigation·2026

Same author

The ENL-USP7 Complex Regulates HIV Latency Through BRD4 Stabilization.

bioRxiv : the preprint server for biology·2026

Same author

Histone decrotonylation plays a distinct role in HIV latency.

Science advances·2026

Same author

Single cell multiomic analysis of the impact of Delta-9-tetrahydrocannabinol on HIV infected CD4 T cells.

Journal of cannabis research·2026

Same journal

Prevention and Control of Clostridioides difficile Infection for the Infectious Diseases Clinician.

Infectious disease clinics of North America·2026

Same journal

Infection Control Strategies to Prevent Emergence and Transmission of Resistant Gram-Negative Bacteria.

Infectious disease clinics of North America·2026

Same journal

Preventing the Spread of Tuberculosis in Health Care Settings.

Infectious disease clinics of North America·2026

Same journal

Threats to Success: Principles of Infection Prevention and Control in Health Care Settings, Part 2: Device and Pathogen Management.

Infectious disease clinics of North America·2026

Same journal

Ventilator-Associated Events: Surveillance and Prevention.

Infectious disease clinics of North America·2026

Same journal

Nosocomial Fungal Infections: Epidemiology, Control Strategies, and Prevention of Candida and Other Yeasts.

Infectious disease clinics of North America·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 21, 2025

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

Advancing Toward a Human Immunodeficiency Virus Cure: Initial Progress on a Difficult Path.

David M Margolis¹

¹Medicine, Microbiology & Immunology, Epidemiology; UNC HIV Cure Center; University of North Carolina at Chapel Hill, 2016 Genetic Medicine Building, 120 Mason Farm Road, CB 7042, Chapel Hill, NC 27599-7042, USA.

Infectious Disease Clinics of North America

|July 5, 2024

Summary

This summary is machine-generated.

Researchers are making progress toward an HIV cure by reversing viral latency and targeting the HIV reservoir during antiretroviral therapy. These advances offer hope for future therapies to eliminate HIV infection.

Keywords:

Clinical trials Eradication HIV infection Latency Persistence

More Related Videos

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection

Published on: January 31, 2020

Stem-cell Based Engineered Immunity Against HIV Infection in the Humanized Mouse Model

Stem-cell Based Engineered Immunity Against HIV Infection in the Humanized Mouse Model

Published on: July 2, 2016

Related Experiment Videos

Last Updated: Jun 21, 2025

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection

Published on: January 31, 2020

Stem-cell Based Engineered Immunity Against HIV Infection in the Humanized Mouse Model

Stem-cell Based Engineered Immunity Against HIV Infection in the Humanized Mouse Model

Published on: July 2, 2016

Area of Science:

Virology
Immunology
Infectious Diseases

Background:

Lifelong antiretroviral therapy (ART) is currently standard for managing human immunodeficiency virus (HIV) infection.
Eradicating HIV infection completely remains a significant challenge, with a persistent viral reservoir posing a major obstacle.

Purpose of the Study:

To review advances in HIV cure research, focusing on strategies to reverse viral latency.
To discuss the potential of targeting the persistent viral reservoir while ART is maintained.
To highlight improvements in assays and infrastructure crucial for HIV cure research.

Main Methods:

Review of current research in HIV latency reversal.
Analysis of strategies for targeting the latent HIV reservoir.
Assessment of advancements in HIV cure research methodologies.

Main Results:

Significant progress has been made in reversing HIV latency.
ART maintenance allows for effective targeting of the persistent viral reservoir.
Improvements in research assays and infrastructure are enhancing HIV cure research capabilities.

Conclusions:

While a complete HIV cure is not yet available, recent advances provide a hopeful outlook.
Future therapies may be developed to clear HIV infection, reducing the burden on individuals and society.
Continued research into latency reversal and reservoir targeting is essential for achieving an HIV cure.